Dr. Goy on the Clinical Implications of CAR T-Cell Therapy in MCL
Andre Goy, MD, discusses the clinical implications of CAR T-cell therapy in mantle cell lymphoma.
Dr. Goy on the Potential Utility of BTK Inhibitors as Maintenance in MCL
Andre H. Goy, MD, discusses the potential utility of BTK inhibitors as maintenance therapy in mantle cell lymphoma.